Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
about
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acidDescription of focal liver lesions with Gd-EOB-DTPA enhanced MRI25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesThe role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a reviewFocal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRIComparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.Is hepatotropic contrast enhanced MR a more effective method in differential diagnosis of hemangioma than multi-phase CT and unenhanced MR?Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent.Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates.The utility of gadoxetic acid-enhanced MR imaging to characterize atypical cirrhotic nodules detected on dynamic CT images.Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial.Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.The inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function.Gadoxetic acid disodium (Gd-EOBDTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis.Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging.Prospective diagnostic test accuracy comparison of computed tomography during arterial portography and Primovist magnetic resonance imaging in the pre-operative assessment of colorectal cancer liver metastasesValidation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver MetastasisWas Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisationPreoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30° Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or CirrhosisDiagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine.The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver.Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR imagesDiagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)New MR techniques for the detection of liver metastasesInter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA)Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC)Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective!The role of the diffusion sequence in magnetic resonance imaging for the differential diagnosis between hepatocellular carcinoma and benign liver lesionsCost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model.Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging.
P2860
Q26769602-2A8D3D1D-1469-40CD-AA13-6D4C85453947Q26770825-340B8608-5087-492D-AAD8-483F78C41CD2Q26774810-D8FB5581-345C-428F-BA55-BCDA7A04E683Q26828543-C57403CE-A7D0-48B7-B107-510B86E1F0CDQ27028207-EACDBFC9-DBA4-4844-8DB7-87788CB0E090Q30359316-4AE0F10E-BC10-4378-9E50-B100FA817639Q30475181-034E7614-D6E3-4AAB-961B-A02ABC06A174Q34064365-9141B941-5144-4081-AF68-56D4C0610492Q34219619-591A2BB7-31C2-41F6-953B-AF0BC604A54FQ34331579-B02CC972-CB84-48D0-BA18-3316913E983EQ34466458-916504B2-7F85-437C-BD16-120065701CB7Q34562932-B2BED541-18A6-452D-8252-AC4614AF346DQ35035082-13D54DCC-95FB-439F-ADAA-3FAEE56EFE25Q35056708-82406062-3476-42D8-B763-8FA238D54108Q35099283-19AF9334-B905-4FB8-A0E1-9FD7F9FBF44EQ35203565-FF9373D0-FE62-4218-A187-1B0DBC59C212Q35207733-E0A46C03-0114-432A-8B35-1BEBEE4F502AQ35619957-9ACEB094-E56E-475D-9E23-8CFA90F54C80Q36064778-157CE331-24A7-44C8-89FF-1F16E7B1E45DQ36133194-968F267E-6F77-417D-BFF7-BD799936CA2BQ36170512-5AEC5527-75FF-4BD6-89F5-0071BF179F7CQ36201171-CD9916B9-3F26-439A-969E-F56B680C5A44Q36208221-61B0CCF0-7783-41C3-B7F0-EF02C76FF5FDQ36218200-B5D94209-BDC3-4DFB-B857-07D01E24A7B5Q36324520-5AEDEE5E-58B2-4D53-9C4C-FB69F2CBCA81Q36325501-A544FC17-EA6D-482B-8750-3665F706434EQ36326113-7747E5FE-C49B-4458-9771-37E4E000A900Q36326793-35BA9575-12EE-4561-AF9E-7D9014D80D9CQ36343921-6E74F1C3-9CA7-4373-A204-A6E09CABA9F1Q36410397-4A2A7518-EC57-4FBC-A017-A20D04FF6393Q36423114-6295FD92-B2CA-48C7-9C2B-28447BB6D646Q36502861-EAAC3A99-28B3-42E1-98AD-51C895AF908CQ36542919-77C7A6D1-A710-436B-AC7B-5123F82AFBA0Q36688101-BD651227-DED7-4B8E-8779-244D6FE9EBCEQ36802087-1838FEB7-12B7-41FD-B886-940D8263FEE3Q36848127-7D831338-5400-48B1-938F-EB753657D7EEQ37314146-225FBE81-C7AF-4CF2-AF62-DDFD269DDFBDQ37378960-5C4661B6-9AE0-49D5-A400-7F80859FFE53Q37407639-A37D71EF-15F4-4565-AADE-C98F09FE08C8Q37610003-B699791A-191D-404F-B547-3B88EDED0E40
P2860
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Improved detection of focal li ...... with intraoperative findings.
@ast
Improved detection of focal li ...... with intraoperative findings.
@en
type
label
Improved detection of focal li ...... with intraoperative findings.
@ast
Improved detection of focal li ...... with intraoperative findings.
@en
prefLabel
Improved detection of focal li ...... with intraoperative findings.
@ast
Improved detection of focal li ...... with intraoperative findings.
@en
P2093
P1433
P1476
Improved detection of focal li ...... with intraoperative findings.
@en
P2093
Alexander Huppertz
Andrea Giovagnoni
Anthony Blakeborough
Didier G Mathieu
Dieter Mueller
European EOB Study Group
Gertraud Heinz-Peer
Josy Breuer
Matthias Taupitz
Michael Laniado
P304
P356
10.1148/RADIOL.2301020269
P407
P577
2004-01-01T00:00:00Z